Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
| Image |  |
|---|---|
| Description | scientific article published on 29 July 2013 |
| Author/s |
author: Qingzhong Hu Matthias Engel |
| Publication date | July 29, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |